Tackling immune evasion in prostate cancer
Tumor-intrinsic and microenvironmental programs are key determinants of immune escape in prostate cancer.
Immune evasion limits the efficacy of immune checkpoint inhibitors in advanced prostate cancer.
Reprogramming the tumor microenvironment may restore antitumor immunity in prostate cancer.
Mechanistic insights enable precision guided rational combinations to overcome immune resistance.
https://www.cell.com/trends/cancer/fulltext/S2405-8033(26)00162-7
